Back to Journals » OncoTargets and Therapy » Volume 6

Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview

Authors Zhu C, Jin K 

Received 24 November 2012

Accepted for publication 11 January 2013

Published 3 March 2013 Volume 2013:6 Pages 119—124

DOI https://doi.org/10.2147/OTT.S40667

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 7



Chengchu Zhu,1 Ketao Jin2

1Department of Cardiothoracic Surgery, 2Department of Surgical Oncology, Taizhou Hospital, Wenzhou Medical College, Linhai, Zhejiang, People's Republic of China

Abstract: Since its introduction in the People's Republic of China in 1992, minimally invasive esophagectomy (MIE) has shown the classical advantages of minimally invasive surgery over its open counterpart. Like all pioneers of the technique, cardiothoracic surgeons in the People's Republic of China claim that MIE has a lower risk of pulmonary infection, faster recovery, a shorter hospital stay, and a more rapid return to daily activities than open esophagectomy, while offering the same functional and oncologic results. There has been burgeoning interest in MIE in the People's Republic of China since 1995. The last decade has witnessed nationwide growth in the application of MIE and yielded a significant amount of scientific data in support of its clinical merits and advantages. However, no prospective randomized controlled trials have actually investigated the benefits of MIE in the People's Republic of China. Here we review the current data and state of the art MIE treatment for esophageal cancer in the People's Republic of China.

Keywords: esophagectomy, minimally invasive esophagectomy, esophageal cancer, review

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.